首页> 外文期刊>Pertanika Journal of Tropical Agricultural Science >Molecular Characterisation of the GdhA - Derivative of Pasteurella multocida B:2
【24h】

Molecular Characterisation of the GdhA - Derivative of Pasteurella multocida B:2

机译:Muctiourla Multocada的GDHA - 衍生物的分子表征:2

获取原文
获取外文期刊封面目录资料

摘要

Pasteurella multocida B:2 is an important veterinary pathogen causing fatal and acute haemorrhagic septicaemia (HS) in bovine. A live vaccine candidate, P. multocida B:2 GDH7 was reported to enable protection in cattle and buffaloes via intranasal (i. n.) administration. This potential vaccine was also reported to be self-transmitted from the vaccinated animal to the free-ranging animals allowing wider vaccination coverage. Prior to commercialisation, this potential vaccine requires further characterisation in accordance with the authoritative guidelines from the World Organisation for Animal Health (OIE). Hence, in this study, the potential vaccine strain, P. multocida B:2 GDH7 and the virulent parent strain were characterised through genomic and proteomic profiling. A crucial first step was to develop a sensitive yet simple and robust identification test to differentiate both strains which has been achieved by the development of a precise yet straightforward PCR method. In genomic profiling, Repetitive Extragenic Palindromic sequence-PCR (REP-PCR) was manipulated and both strains have a different display of genomic DNA band patterns. Some of the major OMPs were observed and prominent immunogens of P. multocida, OmpA and OmpH were observed to be expressed differently between these strains through SDS-PAGE analysis. In conclusion, a reproducible PCR detection method has enabled differentiation of both strains. Further characterisation of these strains shows a significantly different profile through genomic and proteomic profiling.
机译:Pasteurella multiocida B:2是一种重要的兽医病原体,导致牛粪致命和急性出血性败血症(HS)。据报道,Live疫苗候选者,P. Multiocida B:2 GDH7通过鼻内(I.N)管理来实现牛和水牛的保护。据报道,这种潜在的疫苗还从接种疫苗的动物自传到自由测距动物,允许更宽的疫苗接种覆盖。在商业化之前,这种潜在的疫苗需要根据来自世界动物健康组织(OIE)的权威准则的进一步表征。因此,在该研究中,通过基因组和蛋白质组学分析表征潜在疫苗菌株P. Multiocida B:2GDH7和毒力母体菌株。至关重要的第一步是开发一种敏感但简单且稳健的鉴定测试,以区分通过开发精确但简单的PCR方法而实现的两种菌株。在基因组分析中,操纵重复的含有血糖素序列PCR(REP-PCR),并且两种菌株的基因组DNA带图案都具有不同的显示。观察到一些主要OMP,并观察到Multocida,OMPA和OMPH的显着免疫原,通过SDS-PAGE分析在这些菌株之间不同地表达。总之,可重复的PCR检测方法使得两种菌株的分化。这些菌株的进一步表征通过基因组和蛋白质组分析显示出显着不同的曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号